The Dahlman Lab at Georgia Tech and the Emory School of Medicine (dahlmanlab.org) develops
nanoparticles that deliver mRNA and siRNA drugs. The lab has pioneered high-throughput nanoparticle
assays that utilize DNA barcoding to quantify how thousands of distinct nanoparticles deliver RNA and
DNA drugs in vivo instead of evaluating them in cell culture. More broadly, our lab develops new
technologies at the interface of big data, genomics, and gene therapies.